Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Sophie Tanguay, MSc
Executive Director
Sophie Tanguay has been a decisive leader in drug development, global clinical research, and regulatory affairs at both local and international levels for 25 years. She has spearheaded strategic initiatives that drive innovation, portfolio growth, and regulatory success in the pharmaceutical industry.
Before joining Seriant, Sophie drove the Innovative Product Development and Portfolio Strategy Team, playing a pivotal role in evaluating new technologies, pipelines, and products for mergers and acquisitions (M&A), joint ventures (JV), and in-licensing opportunities. Beyond industry leadership, she has provided strategic insights as a consultant for academic institutions, pharmaceutical companies, and biotechnology organizations. Her expertise spans pharmaceuticals, medical devices, natural health products, consumer goods, and cosmetics, with a deep understanding of the regulatory landscape and clinical development. Her contributions have led to the successful advancement of products in neurology, gastroenterology, oncology, and cardiology.
Sophie holds a Master of Science in Neurobiology and a Bachelor's degree in Molecular Biology from Laval University. At Seriant, she continues to shape the future of clinical research, bringing a strategic, science-driven approach to innovation and patient-centered advancements.
